XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jan. 03, 2026
Dec. 28, 2024
Dec. 30, 2023
Cash flows from operating activities:      
Net income (loss) $ 29,600 $ (28,499) $ (65,901)
Adjustments to reconcile net income (loss) to cash provided by operating activities:      
Depreciation and amortization 91,152 92,680 98,252
Amortization of debt discount and deferred financing costs 1,217 2,121 3,351
Amortization of cloud computing implementation costs 8,741 6,402 3,170
Asset impairment 1,991 40,099 82,413
Deferred income tax expense (benefit) 4,663 (9,975) (5,989)
Stock-based compensation expense 23,686 16,708 20,174
(Gains) on change in fair value of derivatives 0 (34) (1,274)
Inventory adjustments 5,327 4,391 3,707
Other (56) (1,013) 3,891
Changes in operating assets and liabilities:      
Accounts receivable (8,069) 36,399 (7,817)
Inventories (728) 21,598 (457)
Operating lease right of use assets and liabilities (1,822) (2,321) 524
Other assets (45,656) (7,286) (3,171)
Accounts payable 25,356 (13,913) 2,280
Deferred and unearned revenue 12,766 (5,852) 7,401
Other liabilities (1,875) (17,856) 32,479
Net cash provided by operating activities 146,293 133,649 173,033
Cash flows from investing activities:      
Purchase of property and equipment (72,840) (95,505) (114,774)
Other (3,766) (589) (1,048)
Net cash used for investing activities (76,606) (96,094) (115,822)
Cash flows from financing activities:      
Repayments on long-term debt (126,337) (222,064) (103,000)
Borrowings on long-term debt 25,000 115,000 0
Payments of debt issuance costs 0 (1,703) (3,312)
Payments on finance lease obligations (3,475) (2,993) (3,918)
Proceeds from issuance of common stock 3,395 1,507 1,837
Purchase of treasury stock (3,205) (3,092) (28,415)
Net cash used for financing activities (104,622) (113,345) (136,808)
Net change in cash, cash equivalents and restricted cash (34,935) (75,790) (79,597)
Cash, cash equivalents and restricted cash, beginning of year 75,237 151,027 230,624
Cash, cash equivalents and restricted cash, end of year (See Note 3) 40,302 75,237 151,027
Supplemental cash flow disclosure information:      
Cash paid for interest 19,091 13,398 11,735
Capital expenditures accrued at the end of the period $ 12,186 $ 9,248 $ 5,412